Table 2.

Effects of GABA, baclofen, picrotoxin, cAMP analog, IBMX, PKAI, and PKCI on calcium currents

ControlExperimentaldftp
TreatmentnATreatmentnA
−0.95  ± 0.29  (7)GABA* (10 nm)−1.09  ± 0.38  (7)62.5<0.05
−0.17  ± 0.06  (7)GABAI,t (10 nm)−0.23  ± 0.04  (7)63.1<0.025
−0.94  ± 0.30  (7)GABA* (30 μm)−0.67  ± 0.20  (7)63.0<0.025
−1.01  ± 0.11  (9)Baclofen (25 μm)−0.66  ± 0.27  (9)83.4<0.01
GABA (50 nm)−0.78  ± 0.21  (6)GABA (50 nm) + Picro (1 μm)−0.19  ± 0.16  (6)59.5<0.005
−1.28  ± 0.16  (7)Dibu.cAMP (2.5 nm)−2.17  ± 0.33  (7)67.5<0.005
−0.90  ± 0.18  (5)IBMX (200 μm)−1.16  ± 0.21  (5)44.3<0.025
PKAI (5 μm)−1.00  ± 0.21  (5)PKAI (5 μm) + GABA (50 nm)−0.43  ± 0.13  (5)44.8<0.01
PKCI (5 μm)−1.08  ± 0.26  (6)PKCI (5 μm) + GABA (25 μm)−0.57  ± 0.12  (6)53.7<0.025
  • Asterisk indicates that the Vh was −30 mV and step potential was +20 mV. Vh for other experiments was −80 mV, and the step voltage was −20 mV. The transient component of the calcium current (It) was elicited from a holding potential of −80 mV to step potentials of −10 mV. Data are expressed as the mean peak current ± SD (number of cells). Computed t statistics are for tests of correlated means. Picro, Picrotoxin; dibu.cAMP, cAMP-N6,O6-dibutyril.